Outlier tests (EMA) [Outliers]

posted by Dr_Dan  – Germany, 2010-06-15 14:36 (5502 d 18:11 ago) – Posting: # 5513
Views: 19,732

Dear Helmut and all
At the EGA workshop you mentioned Lorelei Lutter pointed out the contradiction in the guideline: On the one hand no outlier test is accepted in order to evaluate the results of a BE study and on the other hand it should be demonstrated that the high within-subject variability in a replicate study is not the result of outliers. The whole problem with outliers is not solved by the regulatory authorities and they refuse to discuss this. Why should I detect outliers if no outlier test is accepted and the whole dataset should be evaluated? I suggest not to perform any outlier test.
I am looking forward to further comments regarding this topic.
Kind regards
Dan

Kind regards and have a nice day
Dr_Dan

Complete thread:

UA Flag
Activity
 Admin contact
23,428 posts in 4,929 threads, 1,695 registered users;
78 visitors (0 registered, 78 guests [including 26 identified bots]).
Forum time: 08:47 CEST (Europe/Vienna)

If I’d observed all the rules,
I’d never have got anywhere.    Marilyn Monroe

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5